Benzodiazepine use and cognitive function among community-dwelling elderly

被引:149
作者
Hanlon, JT
Horner, RD
Schmader, KE
Fillenbaum, GG
Lewis, IK
Wall, WE
Landerman, LR
Pieper, CF
Blazer, DG
Cohen, HJ
机构
[1] Duke Univ, Med Ctr, Ctr Study Aging & Human Dev, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Dept Med, Div Geriatr Med, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Community & Family Med, Div Biometry, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[6] Vet Affairs Med Ctr, Dept Pharm, Durham, NC 27705 USA
[7] Ctr Geriatr Res Educ & Clin, Ctr Hlth Serv Res Primary Care, Durham, NC USA
[8] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27515 USA
关键词
D O I
10.1016/S0009-9236(98)90059-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate the relation between benzodiazepine use and cognitive function among community-dwelling elderly. Methods This prospective cohort study included 2765 self-reporting subjects from the Duke Established Populations for Epidemiologic Studies of the Elderly. The subjects were cognitively intact at baseline (1986-1987) and alive at follow-up data collection 3 years later. Cognitive function was assessed with the Short Portable Mental Status Questionnaire (unimpaired versus impaired and change in score) and on the basis of the number of errors on the individual domains of the Orientation-Memory-Concentration Test. Benzodiazepine use was determined during in-home interviews and classified by dose, half-life, and duration. Covariates included demographic characteristics, health status, and health behaviors. Results: After control for covariates, current users of benzodiazepine made more errors on the memory test (beta coefficient, 0.35; 95% confidence interval [CI], 0.10 to 0.61) than nonusers. Further assessment of the negative effects on memory among current users suggested a dose response in which users taking the recommended or higher dose made more errors (beta coefficient, 0.57; 95% CT, 0.26 to 0.88) and a duration response in which long-term users made more errors (bt-ta coefficient, 0.39; 95% CI, 0.05 to 0.73) than nonusers. Users of agents with long half-lives and users of agents with short half-lives both had increased memory impairment (beta coefficient, 0.32; 95% CI, 0.01 to 0.64 and beta coefficient, 0.38; 95% CI, 0.02 to 0.75, respectively) relative to nonusers. Previous benzodiazepine use was unrelated to memory problems, and current and previous benzodiazepine use was unrelated to level of cognitive functioning as measured with the other 4 tests. Conclusions: The results suggested that current benzodiazepine use, especially in recommended or higher doses, is associated with worse memory among community-dwelling elderly.
引用
收藏
页码:684 / 692
页数:9
相关论文
共 62 条
  • [1] [Anonymous], 1989, Applied Linear Regression Models
  • [2] APPLEGATE WB, 1990, NEW ENGL J MED, V322, P1207
  • [3] REVERSIBLE DEMENTIAS
    ARNOLD, SE
    KUMAR, A
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 1993, 77 (01) : 215 - 230
  • [4] BARBEE JG, 1993, J CLIN PSYCHIAT, V54, P86
  • [5] The use of psychoactive medications and cognitive function in older adults
    Berg, S
    Dellasega, C
    [J]. JOURNAL OF AGING AND HEALTH, 1996, 8 (01) : 136 - 149
  • [6] THE ASSOCIATION OF AGE AND DEPRESSION AMONG THE ELDERLY - AN EPIDEMIOLOGIC EXPLORATION
    BLAZER, D
    BURCHETT, B
    SERVICE, C
    GEORGE, LK
    [J]. JOURNALS OF GERONTOLOGY, 1991, 46 (06): : M210 - M215
  • [7] DRUG-INDUCED COGNITIVE IMPAIRMENT - DEFINING THE PROBLEM AND FINDING SOLUTIONS
    BOWEN, JD
    LARSON, EB
    [J]. DRUGS & AGING, 1993, 3 (04) : 349 - 357
  • [8] METHODS FOR ASSESSING DIFFERENCE BETWEEN GROUPS IN CHANGE WHEN INITIAL MEASUREMENT IS SUBJECT TO INTRAINDIVIDUAL VARIATION
    CHAMBLESS, LE
    ROEBACK, JR
    [J]. STATISTICS IN MEDICINE, 1993, 12 (13) : 1213 - 1237
  • [9] COLSHER PL, 1991, EPIDEMIOL REV, V13, P1
  • [10] Cornoni-Huntley J., 1990, NIH PUBLICATION, VII